1. Home
  2. YSWY vs OBX Comparison

YSWY vs OBX Comparison

Compare YSWY & OBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yesway Inc. Class A Common Stock

YSWY

Yesway Inc. Class A Common Stock

N/A

Current Price

$24.74

Market Cap

764.2M

ML Signal

N/A

Logo Obsidian Therapeutics Inc. Common Stock

OBX

Obsidian Therapeutics Inc. Common Stock

N/A

Current Price

$14.00

Market Cap

861.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSWY
OBX
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
764.2M
861.1M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
YSWY
OBX
Price
$24.74
$14.00
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$29.63
★ $39.00
AVG Volume (30 Days)
248.9K
★ 300.4K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$23.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.92
$11.52
52 Week High
$26.34
$39.00

Technical Indicators

Market Signals
Indicator
YSWY
OBX
Relative Strength Index (RSI) 65.76 47.42
Support Level $18.92 $11.84
Resistance Level $26.34 $19.97
Average True Range (ATR) 0.93 1.09
MACD 0.24 0.40
Stochastic Oscillator 87.61 56.78

Price Performance

Historical Comparison
YSWY
OBX

About YSWY Yesway Inc. Class A Common Stock

Yesway Inc is a U.S.-based convenience store operator that manages retail locations under the Yesway and Allsup's brands. Its stores offer foodservice products, grocery items, and private-label products. The company operates in rural and suburban markets across the Southwest and Midwest regions of the United States. It derives its revenue in the United States by operating convenience stores that offer merchandise, fuel, and other products and services designed to appeal to the convenience needs of the customers.

About OBX Obsidian Therapeutics Inc. Common Stock

Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.

Share on Social Networks: